Sifting the literature for real-world challenges thwarting adoption of clinical AI across medicine, a team of biomedical engineers and computer scientists has identified and fleshed out an exemplary use case.

The Food and Drug Administration has approved a new drug that claims to slow the progression of Alzheimer’s disease. The drug is the first approved for Alzheimer’s disease since 2003.

The vast majority of healthcare executives say digital transformation across their organizations is accelerating, according to a recent survey of 399 executives from six countries.

Virtual care, remote patient monitoring and AI-based research are three specific topics the groups are expected to discuss.

AFib patients undergoing cardiac surgery may benefit from concomitant LAAO, according to a new study in the New England Journal of Medicine.

Deficiencies in healthcare systems are emerging in states with some of the fastest growing populations.

Healthcare AI has potential not only for neutralizing its inherent algorithmic bias but also for personalizing its outputs to help humans address health inequities.

This issue “has the potential to inhibit lifesaving therapies,” according to a new analysis in the Journal of the American Heart Association.